Cost-Effectiveness of Targeted Prophylaxis among Allogenic Stem Cell Transplant Recipients

Cost-Effectiveness of Targeted Prophylaxis among Allogenic Stem Cell Transplant Recipients

Bloodstream infections (BSI) are life-threatening complications for onco-hematologic patients. Fluoroquinolones prophylaxis (FQP) was recommended for patients with neutropenia. Later, it was correlated with increased resistance rates among this population and its role became debated. While the role...

Full description

Bibliographic Details
Main Authors:	Nour Shbaklo, Costanza Vicentini, Alessandro Busca, Luisa Giaccone, Chiara Dellacasa, Irene Dogliotti, Tommaso Lupia, Carla M. Zotti, Silvia Corcione, Francesco Giuseppe De Rosa
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	Pharmaceuticals
Subjects:	antibiotic prophylaxis bloodstream infections onco-hematologic transplant multi-drug resistant infections cost-effectiveness analysis
Online Access:	https://www.mdpi.com/1424-8247/16/3/466

Similar Items

Bacterial Bloodstream Infections after Allogeneic Hematopoietic Stem Cell Transplantation: Etiology, Risk Factors and Outcome in a Single-Center Study
by: Jessica Gill, et al.
Published: (2023-03-01)

Levofloxacin prophylaxis omission in acute myeloid leukemia during post induction aplasia: a single center study
by: Irene Urbino, et al.
Published: (2023-02-01)

Increasing Gram-Negative Catheter-Related Bloodstream Infection in Cancer Patients
by: Julia Laporte-Amargos, et al.
Published: (2023-02-01)

Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience
by: Alessandro Busca, et al.
Published: (2022-01-01)

Universal antifungal prophylaxis effectively prevents fungal bloodstream infection in pediatric liver transplant recipients: a retrospective real-world study
by: Weili Wang, et al.
Published: (2024-06-01)

Management of infectious endocarditis from the perspective of the Infectious Diseases specialist – a 2023 update
by: Oana-Alexandra Ganea, et al.
Published: (2023-03-01)

Management of the febrile neutropenic patient in 2023
by: David-Valentin Mangaloiu, et al.
Published: (2023-03-01)

PCR-based rapid identification of methicillin-resistant Staphylococcus aureus strains and their antibiotic resistance profiles in febrile neutropenic patients
by: Maggie Ibrahim, et al.
Published: (2023-11-01)

Epidemiology, resistant pathogens, and causes of early death in cases of bloodstream infection in patients with hematological malignancies from 2012–2019
by: Meng Li, et al.
Published: (2022-03-01)

The Use of Voriconazole as Primary Prophylaxis for Invasive Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation: A Single Center’s Experience
by: Ali Atoui, et al.
Published: (2021-10-01)

Breakthrough Invasive Fungal Infections in Allogeneic Hematopoietic Stem Cell Transplantation
by: Carmine Liberatore, et al.
Published: (2021-04-01)

Ceftobiprole Perspective: Current and Potential Future Indications
by: Tommaso Lupia, et al.
Published: (2021-02-01)

Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4)
by: Can Boğa, et al.
Published: (2015-05-01)

Infection Control in the Era of COVID-19: A Narrative Review
by: Nour Shbaklo, et al.
Published: (2021-10-01)

<i>Stenotrophomonas maltophilia</i> Infections in Haematological Malignancies and Hematopoietic Stem Cell Transplantation: A Case Series including Cefiderocol-Based Regimens
by: Tommaso Lupia, et al.
Published: (2024-01-01)

Use of Letermovir for CMV Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: Review of the Literature and Single-Center Real-Life Experience
by: Jessica Gill, et al.
Published: (2023-04-01)

Ten Years of KPC-Kp Bloodstream Infections Experience: Impact of Early Appropriate Empirical Therapy on Mortality
by: Silvia Corcione, et al.
Published: (2022-12-01)

Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol)
by: Michele Malagola, et al.
Published: (2022-06-01)

Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole
by: Oliveira J.S.R., et al.
Published: (2002-01-01)

Role of Sirtuins in the Pathobiology of Onco-Hematological Diseases: A PROSPERO-Registered Study and In Silico Analysis
by: João Vitor Caetano Goes, et al.
Published: (2022-09-01)

Liquid Biopsy in Cancer: Focus on Lymphoproliferative Disorders
by: Francesco D. Savino, et al.
Published: (2022-10-01)

Two cases of paralitic ileus in onco-hematologic patients
by: Francesca Carraro, et al.
Published: (2012-01-01)

Infective endocarditis: prevention and antibiotic prophylaxis
by: Swiss Medical Weekly, et al.
Published: (2021-02-01)

Baseline Chest Computed Tomography as Standard of Care in High-Risk Hematology Patients
by: Jannik Stemler, et al.
Published: (2020-03-01)

Bacterial and Viral Infections in Liver Transplantation: New Insights from Clinical and Surgical Perspectives
by: Nour Shbaklo, et al.
Published: (2022-06-01)

Matriz extracelular e enzimas degradatórias na hematopoese e doenças onco-hematológicas Extracellular matrix in hematopoiesis and hematologic malignancies
by: Juliana L. Dreyfuss, et al.
Published: (2008-10-01)

Antibiotic Prophylaxis for Ocular Surgical Infections
by: Ufuk Elgin
Published: (2011-10-01)

Antibiotic De-escalation Experience in the Setting of Emergency Department: A Retrospective, Observational Study
by: Silvia Corcione, et al.
Published: (2021-07-01)

Role of Oritavancin in the Treatment of Infective Endocarditis, Catheter- or Device-Related Infections, Bloodstream Infections, and Bone and Prosthetic Joint Infections in Humans: Narrative Review and Possible Developments
by: Tommaso Lupia, et al.
Published: (2023-04-01)

Optimal timing of antimicrobial prophylaxis before surgery
by: Saarat Sathoo, et al.
Published: (2021-12-01)

Cytomegalovirus in renal transplant recipients from living donors with and without valganciclovir prophylaxis and with immunosuppression based on anti-thymocyte globulin or basiliximab
by: Jorge Andrade-Sierra, et al.
Published: (2021-06-01)

Antifungal Prophylaxis in Solid Organ Transplant Recipients
by: Şebnem ŞENOL, et al.
Published: (2015-12-01)

Clinical, economic and organizational impact of pharmacist interventions on injectable antineoplastic prescriptions: a prospective observational study
by: Céline Zecchini, et al.
Published: (2020-02-01)

Current Approaches to Surgical Antimicrobial Prophylaxis and Use of Antimicrobial Prophylaxis in Urological Procedures
by: Pınar Şen, et al.
Published: (2017-12-01)

Infective Endocarditis in Children — New Approach in Antimicrobial Prophylaxis
by: Togănel Rodica
Published: (2016-06-01)

Invasive Fungal Breakthrough Infections under Targeted Echinocandin Prophylaxis in High-Risk Liver Transplant Recipients
by: Robert Breitkopf, et al.
Published: (2023-02-01)

Bloodstream Infections among Solid Organ Transplant Recipients: Eight Years’ Experience from a Turkish University Hospital
by: Ayşegül Yeşilkaya, et al.
Published: (2013-09-01)

A clinical analysis of Candida tropicalis bloodstream infections associated with hematological diseases, and antifungal susceptibility: a retrospective survey
by: Beibei Yang, et al.
Published: (2023-07-01)

Changing epidemiology and prognosis of nosocomial bloodstream infection: A single-center retrospective study in Taiwan
by: Wei-Chih Liao, et al.
Published: (2022-12-01)

Antibiotic Prophylaxis in Elective Hand Surgery
by: Carolina Vasconcelos, et al.
Published: (2017-11-01)